Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Reprogramming of the developing heart by Hif1a-deficient sympathetic system and maternal diabetes exposure

H. Kolesova, P. Hrabalova, R. Bohuslavova, P. Abaffy, V. Fabriciova, D. Sedmera, G. Pavlinkova

. 2024 ; 15 (-) : 1344074. [pub] 20240305

Language English Country Switzerland

Document type Journal Article

INTRODUCTION: Maternal diabetes is a recognized risk factor for both short-term and long-term complications in offspring. Beyond the direct teratogenicity of maternal diabetes, the intrauterine environment can influence the offspring's cardiovascular health. Abnormalities in the cardiac sympathetic system are implicated in conditions such as sudden infant death syndrome, cardiac arrhythmic death, heart failure, and certain congenital heart defects in children from diabetic pregnancies. However, the mechanisms by which maternal diabetes affects the development of the cardiac sympathetic system and, consequently, heightens health risks and predisposes to cardiovascular disease remain poorly understood. METHODS AND RESULTS: In the mouse model, we performed a comprehensive analysis of the combined impact of a Hif1a-deficient sympathetic system and the maternal diabetes environment on both heart development and the formation of the cardiac sympathetic system. The synergic negative effect of exposure to maternal diabetes and Hif1a deficiency resulted in the most pronounced deficit in cardiac sympathetic innervation and the development of the adrenal medulla. Abnormalities in the cardiac sympathetic system were accompanied by a smaller heart, reduced ventricular wall thickness, and dilated subepicardial veins and coronary arteries in the myocardium, along with anomalies in the branching and connections of the main coronary arteries. Transcriptional profiling by RNA sequencing (RNA-seq) revealed significant transcriptome changes in Hif1a-deficient sympathetic neurons, primarily associated with cell cycle regulation, proliferation, and mitosis, explaining the shrinkage of the sympathetic neuron population. DISCUSSION: Our data demonstrate that a failure to adequately activate the HIF-1α regulatory pathway, particularly in the context of maternal diabetes, may contribute to abnormalities in the cardiac sympathetic system. In conclusion, our findings indicate that the interplay between deficiencies in the cardiac sympathetic system and subtle structural alternations in the vasculature, microvasculature, and myocardium during heart development not only increases the risk of cardiovascular disease but also diminishes the adaptability to the stress associated with the transition to extrauterine life, thus increasing the risk of neonatal death.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc24006788
003      
CZ-PrNML
005      
20240624143236.0
007      
ta
008      
240412e20240305sz f 000 0|eng||
009      
AR
024    7_
$a 10.3389/fendo.2024.1344074 $2 doi
035    __
$a (PubMed)38505753
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Kolesova, Hana $u Institute of Anatomy, First Faculty of Medicine, Charles University, Prague, Czechia $u Department of Developmental Cardiology, Institute of Physiology Czech Academy of Sciences (CAS), Prague, Czechia
245    10
$a Reprogramming of the developing heart by Hif1a-deficient sympathetic system and maternal diabetes exposure / $c H. Kolesova, P. Hrabalova, R. Bohuslavova, P. Abaffy, V. Fabriciova, D. Sedmera, G. Pavlinkova
520    9_
$a INTRODUCTION: Maternal diabetes is a recognized risk factor for both short-term and long-term complications in offspring. Beyond the direct teratogenicity of maternal diabetes, the intrauterine environment can influence the offspring's cardiovascular health. Abnormalities in the cardiac sympathetic system are implicated in conditions such as sudden infant death syndrome, cardiac arrhythmic death, heart failure, and certain congenital heart defects in children from diabetic pregnancies. However, the mechanisms by which maternal diabetes affects the development of the cardiac sympathetic system and, consequently, heightens health risks and predisposes to cardiovascular disease remain poorly understood. METHODS AND RESULTS: In the mouse model, we performed a comprehensive analysis of the combined impact of a Hif1a-deficient sympathetic system and the maternal diabetes environment on both heart development and the formation of the cardiac sympathetic system. The synergic negative effect of exposure to maternal diabetes and Hif1a deficiency resulted in the most pronounced deficit in cardiac sympathetic innervation and the development of the adrenal medulla. Abnormalities in the cardiac sympathetic system were accompanied by a smaller heart, reduced ventricular wall thickness, and dilated subepicardial veins and coronary arteries in the myocardium, along with anomalies in the branching and connections of the main coronary arteries. Transcriptional profiling by RNA sequencing (RNA-seq) revealed significant transcriptome changes in Hif1a-deficient sympathetic neurons, primarily associated with cell cycle regulation, proliferation, and mitosis, explaining the shrinkage of the sympathetic neuron population. DISCUSSION: Our data demonstrate that a failure to adequately activate the HIF-1α regulatory pathway, particularly in the context of maternal diabetes, may contribute to abnormalities in the cardiac sympathetic system. In conclusion, our findings indicate that the interplay between deficiencies in the cardiac sympathetic system and subtle structural alternations in the vasculature, microvasculature, and myocardium during heart development not only increases the risk of cardiovascular disease but also diminishes the adaptability to the stress associated with the transition to extrauterine life, thus increasing the risk of neonatal death.
650    _2
$a zvířata $7 D000818
650    _2
$a dítě $7 D002648
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a novorozenec $7 D007231
650    _2
$a myši $7 D051379
650    _2
$a těhotenství $7 D011247
650    12
$a kardiovaskulární nemoci $x metabolismus $7 D002318
650    12
$a gestační diabetes $x metabolismus $7 D016640
650    _2
$a srdce $7 D006321
650    12
$a srdeční selhání $7 D006333
650    _2
$a myokard $x metabolismus $7 D009206
650    _2
$a faktor 1 indukovatelný hypoxií - podjednotka alfa $x metabolismus $7 D051795
655    _2
$a časopisecké články $7 D016428
700    1_
$a Hrabalova, Petra $u Laboratory of Molecular Pathogenetics, Institute of Biotechnology Czech Academy of Sciences (CAS), BIOCEV, Vestec, Czechia $u Faculty of Science, Charles University, Prague, Czechia
700    1_
$a Bohuslavova, Romana $u Laboratory of Molecular Pathogenetics, Institute of Biotechnology Czech Academy of Sciences (CAS), BIOCEV, Vestec, Czechia
700    1_
$a Abaffy, Pavel $u Laboratory of Gene Expression, Institute of Biotechnology Czech Academy of Sciences (CAS), BIOCEV, Vestec, Czechia
700    1_
$a Fabriciova, Valeria $u Laboratory of Molecular Pathogenetics, Institute of Biotechnology Czech Academy of Sciences (CAS), BIOCEV, Vestec, Czechia
700    1_
$a Sedmera, David $u Institute of Anatomy, First Faculty of Medicine, Charles University, Prague, Czechia $u Department of Developmental Cardiology, Institute of Physiology Czech Academy of Sciences (CAS), Prague, Czechia
700    1_
$a Pavlínková, Gabriela, $u Laboratory of Molecular Pathogenetics, Institute of Biotechnology Czech Academy of Sciences (CAS), BIOCEV, Vestec, Czechia $d 1966- $7 xx0319150
773    0_
$w MED00174543 $t Frontiers in endocrinology $x 1664-2392 $g Roč. 15 (20240305), s. 1344074
856    41
$u https://pubmed.ncbi.nlm.nih.gov/38505753 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20240412 $b ABA008
991    __
$a 20240624143234 $b ABA008
999    __
$a ok $b bmc $g 2081023 $s 1216555
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2024 $b 15 $c - $d 1344074 $e 20240305 $i 1664-2392 $m Frontiers in endocrinology $n Front. endocrinol. $x MED00174543
LZP    __
$a Pubmed-20240412

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...